The World of Health & Medicine News

Your daily orange juice could be helping your heart

Your daily orange juice could be helping your heart

Most of us think of orange juice as a simple breakfast habit, something you pour without much thought. Yet scientists are discovering that this everyday drink may be doing far more in the body than quenching thirst.

A recent study has shown that regular orange juice consumption can influence the activity of thousands of genes inside our immune cells. Many of these genes help control blood pressure, calm inflammation and manage the way the body processes sugar, all of which play an important role in long-term heart health.

The study followed adults who drank 500ml of pure pasteurized orange juice every day for two months. After 60 days, many genes associated with inflammation and higher blood pressure had become less active.

These included NAMPT, IL6, IL1B and NLRP3, which usually switch on when the body is under stress. Another gene known as SGK1, which affects the kidneys’ ability to hold onto sodium (salt), also became less active.

Such changes match previous findings that daily orange juice drinking can reduce blood pressure in young adults.

This is noteworthy because it offers a possible explanation for why orange juice has been linked to better heart health in several trials. The new work shows that the drink does not simply raise blood sugar. Instead, it appears to trigger small shifts in the body’s regulatory systems that reduce inflammation and help blood vessels relax.

Natural compounds in oranges, particularly hesperidin, a citrus flavonoid known for its antioxidant and anti-inflammatory effects, seem to influence processes related to high blood pressure, cholesterol balance and the way the body handles sugar.

The response also varies by body size. People carrying more weight tended to show greater changes in genes involved in fat metabolism, while leaner volunteers showed stronger effects on inflammation.

 

spot_img

Explore more

spot_img

The One Healthy Food That Might be Spiking Your ‘Bad’ Cholesterol

The One Healthy Food That Might be Spiking Your 'Bad' Cholesterol Coconut oil has enjoyed a long run as a wellness favorite. It's been blended...

US FDA approves Vertex’s gene therapy for sickle cell disease in...

US FDA approves Vertex's gene therapy for sickle cell disease in children as young as two The U.S. Food and Drug Administration approved expanded use...

FDA clears Orca’s blood cancer therapy to reduce stem cell transplant...

FDA clears Orca's blood cancer therapy to reduce stem cell transplant complications The U.S. Food and Drug Administration said on ​Tuesday it has approved Orca...

US FDA greenlights Viridian’s thyroid eye disease drug

US FDA greenlights Viridian's thyroid eye disease drug The U.S. Food and Drug Administration has approved Viridian Therapeutics' (VRDN.O), opens new tab drug to treat patients ​with...

GLP-1s linked to smell and taste impairment in diabetes patients

GLP-1s linked to smell and taste impairment in diabetes patients Long-term use of GLP-1 drugs ‌for diabetes was associated with an increased risk of disturbances...

Daewoong targets 100,000 beds, ₩300 bil. in digital health push with...

Daewoong targets 100,000 beds, ₩300 bil. in digital health push with AI monitoring platform Hospitals in Korea are quietly experimenting with a new way to...

US FDA proposes framework to speed rare disease gene therapy approvals

US FDA proposes framework to speed rare disease gene therapy approvals The U.S. Food and Drug Administration proposed on Monday a new framework to speed...

AstraZeneca’s fixed-duration Calquence combo wins FDA nod as BeOne CLL rivalry...

AstraZeneca's fixed-duration Calquence combo wins FDA nod as BeOne CLL rivalry heats up AstraZeneca has secured a key regulatory win in its effort to reclaim the lead...